Services Available at United States Addiction Treatment Facilities That Offer Medications versus Behavioral Treatment Only: A Cross-Sectional, Observational Analysis

Andrea Weber; Benjamin Miskle; Alison Lynch; Stephan Arndt; Laura Acion

doi:10.2147/SAR.S356131

Back

Services Available at United States Addiction Treatment Facilities That Offer Medications versus Behavioral Treatment Only: A Cross-Sectional, Observational Analysis

Journal article

Open access

Peer reviewed

Services Available at United States Addiction Treatment Facilities That Offer Medications versus Behavioral Treatment Only: A Cross-Sectional, Observational Analysis

Andrea Weber, Benjamin Miskle, Alison Lynch, Stephan Arndt and Laura Acion

Substance abuse and rehabilitation, Vol.13, pp.57-64

09/30/2022

DOI: 10.2147/SAR.S356131

PMID: 36105487

Files and links (1)

url

https://doi.org/10.2147/SAR.S356131View

Published (Version of record) Open Access

Abstract

Purpose: Substance use disorders (SUDs) are widespread and cause significant morbidity and mortality, yet most people in the United States with a SUD do not receive treatment. Recommendations call for widespread use of pharmacotherapy, including medications for opioid use disorder (MOUD). However, many facilities do not offer a full array of medication treatments. This study aims to characterize programs that do and do not offer pharmacotherapy as part of addiction treatment services. We hypothesized that the availability of pharmacotherapy would predict the existence of other recommended components of treatment.Patients and Methods: We analyzed characteristics regarding treatment facilities (n = 15,782) recorded by the 2019 National Survey of Substance Abuse Treatment Services (N-SSATS) to determine how many SUD treatment facilities offer any pharmacotherapy. We compared facilities that offer any pharmacotherapy to facilities that offer none.Results: We found that 65% of SUD treatment facilities that responded to the N-SSATS survey provided at least one pharmacotherapy, while 35% of SUD treatment facilities did not. The facilities that provided at least one pharmacotherapy offered, on average, 6 additional treatment options (Cohen's d = 0.87; 95% CI: 0.84-0.91). Psychiatric medications were the most commonly available pharmacotherapy, followed by buprenorphine/naloxone and naltrexone.Conclusion: These results support that pharmacotherapy availability, such as MOUD, at SUD treatment facilities is associated with an increased number of recommended treatment components. Since MOUD has been shown elsewhere to reduce mortality for people with OUD, it should be universally available at SUD treatment facilities. Further efforts are needed to make pharmacotherapy more widely available.

Substance Abuse

Life Sciences & Biomedicine

Science & Technology

Details

Title: Subtitle: Services Available at United States Addiction Treatment Facilities That Offer Medications versus Behavioral Treatment Only: A Cross-Sectional, Observational Analysis
Creators: Andrea Weber - University of Iowa Health Care
Benjamin Miskle - University of Iowa, Addiction Medicine
Alison Lynch - University of Iowa Health Care
Stephan Arndt - University of Iowa
Laura Acion - Universidad de Buenos Aires
Resource Type: Journal article
Publication Details: Substance abuse and rehabilitation, Vol.13, pp.57-64
DOI: 10.2147/SAR.S356131
PMID: 36105487
NLM abbreviation: Subst Abuse Rehabil
ISSN: 1179-8467
eISSN: 1179-8467
Publisher: Dove Medical Press Ltd
Number of pages: 8
Language: English
Date published: 09/30/2022
Academic Unit: Psychiatry; Biostatistics; Addiction Medicine; Family and Community Medicine; Nursing; Pharmacy Practice and Science; Injury Prevention Research Center; Internal Medicine
Record Identifier: 9985134049802771

Metrics

1 Record Views

3 Times Cited - Web of Science